I suppose there are a few of us who can't lower our LDL enough with the highest dose of atorvastatin. But let's be clear that that's the generic atorvastatin rather than the branded Lipitor which has no raison d'etre. In this small fraction of the population, I could see a case being made for high dose Crestor (not yet available as generic rosuvastatin). However, I'd also want to warn my patient that we're trading proven outcome benefits (lowering risk of cardiovascular events) for proven LDL lowering.
In fact, a review editorial was published last week in JAMA Internal Medicine in which the authors were even more hard line and found no reason whatsoever for prescribing the two newest brand only statins. I suppose if the copay is the same to you regardless of which statin was prescribed, you might not care. But remember that any expenses are traced back to corporate headquarters such that your insurance rate may be going up next year. So perhaps it's not really free after all.
Tweet
This site complies with the HONcode standard for trustworthy health information:
verify here.
No comments:
Post a Comment